Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$2.2 - $6.01 $770,000 - $2.1 Million
-350,000 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$6.0 - $9.92 $900,000 - $1.49 Million
-150,000 Reduced 30.0%
350,000 $2.25 Million
Q3 2021

Nov 09, 2021

BUY
$6.98 - $12.03 $3.49 Million - $6.02 Million
500,000 New
500,000 $3.54 Million

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $358M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.